Victoria, Australia

Taylor Zhou

This inventor holds 1 USPTO granted patent. Top assignee: Adherium (Nz) Limited. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taylor Zhou: Innovator in Inhaler Technology

Introduction

Taylor Zhou is an accomplished inventor based in Victoria, Australia. He has made significant contributions to the field of medical technology, particularly in the area of inhaler usage monitoring. His innovative approach aims to improve patient adherence to inhaler prescriptions, ultimately enhancing health outcomes.

Latest Patents

Taylor Zhou holds a patent for an inhaler usage monitor. This device is designed to track and record the usage of inhalers, providing valuable data that can help healthcare providers ensure that patients are using their medications correctly. The patent reflects his commitment to advancing healthcare technology and improving patient care.

Career Highlights

Taylor Zhou is currently employed at Adherium (NZ) Limited, a company that specializes in digital health solutions for respiratory conditions. His work at Adherium focuses on developing technologies that support patients in managing their inhaler usage effectively. With his expertise, he has contributed to the company's mission of enhancing medication adherence through innovative solutions.

Collaborations

Taylor has collaborated with notable colleagues, including Stuart Malcolm Cannan and Matthew Gerard Nayna. Together, they work on projects that aim to push the boundaries of inhaler technology and improve patient outcomes.

Conclusion

In summary, Taylor Zhou is a dedicated inventor whose work in inhaler technology is making a significant impact in the healthcare industry. His innovative solutions are paving the way for better patient management and adherence to treatment protocols.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…